

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alkaloid metabolic process (GO:0009820) | 7.35787310 |
| 2 | hormone catabolic process (GO:0042447) | 7.02108222 |
| 3 | * drug metabolic process (GO:0017144) | 6.96776689 |
| 4 | * toxin metabolic process (GO:0009404) | 5.67218052 |
| 5 | polyketide metabolic process (GO:0030638) | 5.36065887 |
| 6 | doxorubicin metabolic process (GO:0044598) | 5.36065887 |
| 7 | daunorubicin metabolic process (GO:0044597) | 5.36065887 |
| 8 | ethanol metabolic process (GO:0006067) | 5.16936029 |
| 9 | cellular response to cadmium ion (GO:0071276) | 5.10592793 |
| 10 | oxidative demethylation (GO:0070989) | 5.07067104 |
| 11 | ethanol oxidation (GO:0006069) | 5.00752133 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 4.97462251 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 4.97462251 |
| 14 | positive regulation of extracellular matrix organization (GO:1903055) | 4.90784866 |
| 15 | epithelial cell-cell adhesion (GO:0090136) | 4.88204582 |
| 16 | desmosome organization (GO:0002934) | 4.87221089 |
| 17 | coenzyme catabolic process (GO:0009109) | 4.80879439 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 4.53735477 |
| 19 | * flavonoid metabolic process (GO:0009812) | 4.51936589 |
| 20 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.51837416 |
| 21 | nitric oxide biosynthetic process (GO:0006809) | 4.49244600 |
| 22 | cellular modified amino acid catabolic process (GO:0042219) | 4.43907166 |
| 23 | vitamin A metabolic process (GO:0006776) | 4.29097854 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.22424672 |
| 25 | retinal metabolic process (GO:0042574) | 4.16449693 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.14455107 |
| 27 | * hydrogen peroxide biosynthetic process (GO:0050665) | 4.11216618 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.06143513 |
| 29 | L-phenylalanine catabolic process (GO:0006559) | 4.06143513 |
| 30 | intestinal absorption (GO:0050892) | 4.02211956 |
| 31 | steroid catabolic process (GO:0006706) | 4.01488945 |
| 32 | vitamin transmembrane transport (GO:0035461) | 4.01352830 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97054287 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.97054287 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 3.96167687 |
| 36 | cellular glucuronidation (GO:0052695) | 3.91871283 |
| 37 | interferon-gamma secretion (GO:0072643) | 3.91817221 |
| 38 | pentose-phosphate shunt (GO:0006098) | 3.89922280 |
| 39 | ear development (GO:0043583) | 3.89717952 |
| 40 | glucose 6-phosphate metabolic process (GO:0051156) | 3.85297963 |
| 41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.83479071 |
| 42 | intestinal epithelial cell development (GO:0060576) | 3.72173693 |
| 43 | heme transport (GO:0015886) | 3.67817186 |
| 44 | hepatocyte apoptotic process (GO:0097284) | 3.62481558 |
| 45 | NADPH regeneration (GO:0006740) | 3.61153633 |
| 46 | regulation of water loss via skin (GO:0033561) | 3.55252670 |
| 47 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.55053319 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 3.54511319 |
| 49 | angiotensin maturation (GO:0002003) | 3.54376328 |
| 50 | * reactive oxygen species biosynthetic process (GO:1903409) | 3.53705565 |
| 51 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.52565913 |
| 52 | norepinephrine metabolic process (GO:0042415) | 3.49632930 |
| 53 | glucose catabolic process (GO:0006007) | 3.48424797 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 3.48071797 |
| 55 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.46369023 |
| 56 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.44066971 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.43844448 |
| 58 | cofactor catabolic process (GO:0051187) | 3.42184734 |
| 59 | glucuronate metabolic process (GO:0019585) | 3.39631396 |
| 60 | uronic acid metabolic process (GO:0006063) | 3.39631396 |
| 61 | primary alcohol metabolic process (GO:0034308) | 3.39214163 |
| 62 | regulation of extracellular matrix organization (GO:1903053) | 3.37806857 |
| 63 | surfactant homeostasis (GO:0043129) | 3.37258847 |
| 64 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.31085821 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.30235937 |
| 66 | somite rostral/caudal axis specification (GO:0032525) | 3.29824543 |
| 67 | multicellular organismal water homeostasis (GO:0050891) | 3.28153257 |
| 68 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.26348245 |
| 69 | primary alcohol catabolic process (GO:0034310) | 3.25579622 |
| 70 | urea cycle (GO:0000050) | 3.24485231 |
| 71 | urea metabolic process (GO:0019627) | 3.24485231 |
| 72 | artery smooth muscle contraction (GO:0014824) | 3.22867279 |
| 73 | transepithelial transport (GO:0070633) | 3.20152559 |
| 74 | homocysteine metabolic process (GO:0050667) | 3.18489301 |
| 75 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17512158 |
| 76 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.16717826 |
| 77 | kynurenine metabolic process (GO:0070189) | 3.16703965 |
| 78 | maintenance of protein location in nucleus (GO:0051457) | 3.15773370 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.14883963 |
| 80 | L-ascorbic acid metabolic process (GO:0019852) | 3.13483612 |
| 81 | negative regulation of sterol transport (GO:0032372) | 3.12602774 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.12602774 |
| 83 | lysine catabolic process (GO:0006554) | 3.12572991 |
| 84 | lysine metabolic process (GO:0006553) | 3.12572991 |
| 85 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.12268718 |
| 86 | positive regulation of hormone metabolic process (GO:0032352) | 3.08983549 |
| 87 | negative regulation of epidermis development (GO:0045683) | 3.08093742 |
| 88 | bile acid biosynthetic process (GO:0006699) | 3.07785619 |
| 89 | cysteine metabolic process (GO:0006534) | 3.06648537 |
| 90 | biotin metabolic process (GO:0006768) | 3.06235402 |
| 91 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.05653737 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.04963838 |
| 93 | regulation of keratinocyte differentiation (GO:0045616) | 3.04898615 |
| 94 | fatty acid derivative transport (GO:1901571) | 3.04594286 |
| 95 | icosanoid transport (GO:0071715) | 3.04594286 |
| 96 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.03268254 |
| 97 | alpha-linolenic acid metabolic process (GO:0036109) | 3.03002835 |
| 98 | regulation of response to osmotic stress (GO:0047484) | 3.02673827 |
| 99 | striated muscle atrophy (GO:0014891) | 3.02182495 |
| 100 | cellular aldehyde metabolic process (GO:0006081) | 3.01134352 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00933246 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00933246 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 2.97723459 |
| 104 | cholesterol homeostasis (GO:0042632) | 2.97262319 |
| 105 | tryptophan catabolic process (GO:0006569) | 2.96963532 |
| 106 | indole-containing compound catabolic process (GO:0042436) | 2.96963532 |
| 107 | indolalkylamine catabolic process (GO:0046218) | 2.96963532 |
| 108 | proline biosynthetic process (GO:0006561) | 2.96765977 |
| 109 | retinol metabolic process (GO:0042572) | 2.96598279 |
| 110 | muscle organ morphogenesis (GO:0048644) | 2.96228996 |
| 111 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.95491564 |
| 112 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.95254675 |
| 113 | protein carboxylation (GO:0018214) | 2.95202643 |
| 114 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.95202643 |
| 115 | triglyceride homeostasis (GO:0070328) | 2.93268289 |
| 116 | acylglycerol homeostasis (GO:0055090) | 2.93268289 |
| 117 | sterol homeostasis (GO:0055092) | 2.92778989 |
| 118 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.92617829 |
| 119 | glutamate metabolic process (GO:0006536) | 2.91382251 |
| 120 | phospholipid efflux (GO:0033700) | 2.91325956 |
| 121 | proline metabolic process (GO:0006560) | 2.90942671 |
| 122 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.90855046 |
| 123 | cytidine metabolic process (GO:0046087) | 2.90324416 |
| 124 | cytidine catabolic process (GO:0006216) | 2.90324416 |
| 125 | cytidine deamination (GO:0009972) | 2.90324416 |
| 126 | axonemal dynein complex assembly (GO:0070286) | 2.89141261 |
| 127 | pentose metabolic process (GO:0019321) | 2.89038927 |
| 128 | NADH metabolic process (GO:0006734) | 2.88769955 |
| 129 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.88233562 |
| 130 | regulation of endothelial cell differentiation (GO:0045601) | 2.88217753 |
| 131 | cholesterol efflux (GO:0033344) | 2.87638696 |
| 132 | tryptophan metabolic process (GO:0006568) | 2.87542637 |
| 133 | gap junction assembly (GO:0016264) | 2.87116020 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 2.87036324 |
| 135 | macromolecular complex remodeling (GO:0034367) | 2.87036324 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 2.87036324 |
| 137 | nucleoside transmembrane transport (GO:1901642) | 2.85643991 |
| 138 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.85491614 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 2.85413897 |
| 140 | bile acid metabolic process (GO:0008206) | 2.80804634 |
| 141 | protein retention in ER lumen (GO:0006621) | 2.80052091 |
| 142 | lipoprotein metabolic process (GO:0042157) | 2.78909123 |
| 143 | regulation of cholesterol esterification (GO:0010872) | 2.76950049 |
| 144 | amino-acid betaine metabolic process (GO:0006577) | 2.74240390 |
| 145 | water homeostasis (GO:0030104) | 2.73795414 |
| 146 | phenol-containing compound catabolic process (GO:0019336) | 2.73444154 |
| 147 | plasma lipoprotein particle clearance (GO:0034381) | 2.72735777 |
| 148 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.72363865 |
| 149 | nucleobase catabolic process (GO:0046113) | 2.72100036 |
| 150 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.70729280 |
| 151 | glyoxylate metabolic process (GO:0046487) | 2.65863779 |
| 152 | muscle atrophy (GO:0014889) | 2.64977193 |
| 153 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.64246661 |
| 154 | skeletal muscle adaptation (GO:0043501) | 2.63408058 |
| 155 | tonic smooth muscle contraction (GO:0014820) | 2.61683923 |
| 156 | membrane lipid catabolic process (GO:0046466) | 2.60411171 |
| 157 | maternal placenta development (GO:0001893) | 2.59019941 |
| 158 | * diterpenoid biosynthetic process (GO:0016102) | 2.58274120 |
| 159 | ER overload response (GO:0006983) | 2.56820394 |
| 160 | NADP metabolic process (GO:0006739) | 2.53554782 |
| 161 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.48394623 |
| 162 | glutathione derivative biosynthetic process (GO:1901687) | 2.47838978 |
| 163 | glutathione derivative metabolic process (GO:1901685) | 2.47838978 |
| 164 | COPII vesicle coating (GO:0048208) | 2.46895756 |
| 165 | carnitine metabolic process (GO:0009437) | 2.46787183 |
| 166 | regulation of cholesterol metabolic process (GO:0090181) | 2.46696128 |
| 167 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.46068657 |
| 168 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.45415435 |
| 169 | vagina development (GO:0060068) | 2.44659587 |
| 170 | establishment of skin barrier (GO:0061436) | 2.44557412 |
| 171 | * epoxygenase P450 pathway (GO:0019373) | 17.4293157 |
| 172 | * omega-hydroxylase P450 pathway (GO:0097267) | 14.7379256 |
| 173 | exogenous drug catabolic process (GO:0042738) | 11.6369138 |
| 174 | drug catabolic process (GO:0042737) | 10.5792316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.84538397 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.49276459 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.62402217 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.62402217 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.62402217 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.32778890 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.88733528 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.69765851 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.57701596 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57226733 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.15098122 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.97317585 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.87171226 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.68573396 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.65274007 |
| 16 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.59792678 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.56264950 |
| 18 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.50725072 |
| 19 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.38458972 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.37478065 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.26748074 |
| 22 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.22006902 |
| 23 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.13247017 |
| 24 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.03714789 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.03126691 |
| 26 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 2.02708586 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02558984 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91155858 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87706974 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87252712 |
| 31 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.86262232 |
| 32 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.79979507 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79280116 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68212483 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65853937 |
| 36 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64435680 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61248430 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56687643 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.55037284 |
| 40 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.46737921 |
| 41 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.44794584 |
| 42 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.44503964 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44488673 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44073318 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.43625398 |
| 46 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.42126852 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41465179 |
| 48 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.41289833 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38524080 |
| 50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36760084 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36254817 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34378870 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34104623 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33985888 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33408089 |
| 56 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32953503 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31912062 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28862383 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28389992 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27518854 |
| 61 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.26685176 |
| 62 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.25514072 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22879121 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18535967 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18484367 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18484367 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17440393 |
| 68 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.17330332 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16594536 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16082326 |
| 71 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15159838 |
| 72 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.14785120 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14664900 |
| 74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14504368 |
| 75 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14148696 |
| 76 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.14054565 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12827395 |
| 78 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12521296 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11265571 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11033238 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10690648 |
| 82 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08941477 |
| 83 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.08271047 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07655338 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06583740 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05608105 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05286783 |
| 88 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04825139 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04136589 |
| 90 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.04052829 |
| 91 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.03735126 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02964069 |
| 93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02568656 |
| 94 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01713939 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01088636 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00185960 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99677441 |
| 98 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98310188 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97717371 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97056234 |
| 101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96434511 |
| 102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96411706 |
| 103 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.96037025 |
| 104 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95728128 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93977929 |
| 106 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.93797944 |
| 107 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93721106 |
| 108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93239002 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93101141 |
| 110 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93036841 |
| 111 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92542707 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91989201 |
| 113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91954325 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90991330 |
| 115 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.90846303 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89669424 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89255393 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88640070 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88451204 |
| 120 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.88054342 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87728648 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87508919 |
| 123 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87355385 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86572276 |
| 125 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86097923 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85969390 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85646290 |
| 128 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85160959 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85129317 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84305978 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83810216 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83374699 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82435491 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.79221287 |
| 135 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77444365 |
| 136 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.77160907 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76759067 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76409301 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76222801 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75729447 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74705208 |
| 142 | * P68_20966046_ChIP-Seq_HELA_Human | 0.72651935 |
| 143 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 0.72612166 |
| 144 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.72411056 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71850634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0008875_abnormal_xenobiotic_pharmacok | 6.99381627 |
| 2 | MP0005360_urolithiasis | 6.18727234 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.44484966 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.04723266 |
| 5 | MP0005365_abnormal_bile_salt | 3.51012594 |
| 6 | MP0004782_abnormal_surfactant_physiolog | 3.34311144 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.99733561 |
| 8 | MP0002254_reproductive_system_inflammat | 2.96360165 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.91249605 |
| 10 | MP0003011_delayed_dark_adaptation | 2.89009924 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.87578200 |
| 12 | MP0003252_abnormal_bile_duct | 2.76488816 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.66339231 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.54241258 |
| 15 | MP0000566_synostosis | 2.47481311 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.45634669 |
| 17 | MP0005501_abnormal_skin_physiology | 2.31807422 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.30662799 |
| 19 | MP0000383_abnormal_hair_follicle | 2.20377438 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.18076054 |
| 21 | MP0005451_abnormal_body_composition | 2.17525469 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.16700886 |
| 23 | MP0010678_abnormal_skin_adnexa | 2.15155580 |
| 24 | MP0004233_abnormal_muscle_weight | 2.07767028 |
| 25 | MP0009840_abnormal_foam_cell | 2.07562132 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.90547459 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.89661434 |
| 28 | MP0004858_abnormal_nervous_system | 1.89414077 |
| 29 | MP0003941_abnormal_skin_development | 1.83928612 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.80627998 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.79140959 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.72561746 |
| 33 | * MP0005319_abnormal_enzyme/_coenzyme | 1.72224110 |
| 34 | MP0005332_abnormal_amino_acid | 1.63900985 |
| 35 | * MP0000609_abnormal_liver_physiology | 1.62279828 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.61030453 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.60255265 |
| 38 | MP0000627_abnormal_mammary_gland | 1.52383723 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.49771220 |
| 40 | MP0005409_darkened_coat_color | 1.47103665 |
| 41 | MP0000377_abnormal_hair_follicle | 1.45966393 |
| 42 | MP0005408_hypopigmentation | 1.45846669 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.44551209 |
| 44 | MP0002132_abnormal_respiratory_system | 1.42319789 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.41712667 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.41464791 |
| 47 | MP0000467_abnormal_esophagus_morphology | 1.37956482 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.35965606 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.33533225 |
| 50 | MP0005499_abnormal_olfactory_system | 1.33533225 |
| 51 | MP0001727_abnormal_embryo_implantation | 1.28118273 |
| 52 | MP0001216_abnormal_epidermal_layer | 1.26427354 |
| 53 | MP0004883_abnormal_blood_vessel | 1.22728202 |
| 54 | MP0005083_abnormal_biliary_tract | 1.22621471 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.22117134 |
| 56 | MP0003878_abnormal_ear_physiology | 1.22117134 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.21551004 |
| 58 | MP0005164_abnormal_response_to | 1.20103090 |
| 59 | MP0001873_stomach_inflammation | 1.18513685 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 1.16665992 |
| 61 | MP0005266_abnormal_metabolism | 1.16517258 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.14200329 |
| 63 | MP0003123_paternal_imprinting | 1.14059981 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.13491605 |
| 65 | MP0002127_abnormal_cardiovascular_syste | 1.12138654 |
| 66 | MP0000579_abnormal_nail_morphology | 1.10927943 |
| 67 | * MP0008872_abnormal_physiological_respon | 1.07822865 |
| 68 | MP0004381_abnormal_hair_follicle | 1.07202073 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 1.06403827 |
| 70 | MP0008260_abnormal_autophagy | 1.04727179 |
| 71 | MP0003693_abnormal_embryo_hatching | 1.02890115 |
| 72 | MP0001849_ear_inflammation | 1.02660309 |
| 73 | MP0005023_abnormal_wound_healing | 0.99408817 |
| 74 | MP0000858_altered_metastatic_potential | 0.99100125 |
| 75 | MP0006292_abnormal_olfactory_placode | 0.98479658 |
| 76 | MP0004043_abnormal_pH_regulation | 0.98457646 |
| 77 | MP0009643_abnormal_urine_homeostasis | 0.97642779 |
| 78 | * MP0000598_abnormal_liver_morphology | 0.95625766 |
| 79 | MP0001881_abnormal_mammary_gland | 0.95319064 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93451977 |
| 81 | MP0000249_abnormal_blood_vessel | 0.93423706 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.92894944 |
| 83 | MP0010771_integument_phenotype | 0.92280903 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.91032726 |
| 85 | MP0001958_emphysema | 0.90660095 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.89097707 |
| 87 | MP0000462_abnormal_digestive_system | 0.88099324 |
| 88 | MP0003195_calcinosis | 0.87548285 |
| 89 | MP0006138_congestive_heart_failure | 0.86738178 |
| 90 | MP0002796_impaired_skin_barrier | 0.86664767 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.85815946 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.84419495 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.83686838 |
| 94 | MP0002060_abnormal_skin_morphology | 0.83581994 |
| 95 | MP0004272_abnormal_basement_membrane | 0.82756013 |
| 96 | MP0003866_abnormal_defecation | 0.82709609 |
| 97 | * MP0008874_decreased_physiological_sensi | 0.82014280 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.81805628 |
| 99 | MP0009672_abnormal_birth_weight | 0.81675557 |
| 100 | MP0010030_abnormal_orbit_morphology | 0.81601203 |
| 101 | MP0006082_CNS_inflammation | 0.81380266 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.80546605 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.76342362 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.75639700 |
| 105 | MP0003936_abnormal_reproductive_system | 0.75423872 |
| 106 | MP0001177_atelectasis | 0.75353851 |
| 107 | MP0003868_abnormal_feces_composition | 0.74338085 |
| 108 | MP0000343_altered_response_to | 0.74081355 |
| 109 | MP0009053_abnormal_anal_canal | 0.73369391 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.72715993 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.71927849 |
| 112 | MP0003122_maternal_imprinting | 0.71199421 |
| 113 | MP0009931_abnormal_skin_appearance | 0.70728672 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.70364403 |
| 115 | MP0002086_abnormal_extraembryonic_tissu | 0.70309326 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.69572516 |
| 117 | MP0003984_embryonic_growth_retardation | 0.69406552 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.69358694 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.69308411 |
| 120 | MP0002925_abnormal_cardiovascular_devel | 0.68429814 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.67025505 |
| 122 | MP0005670_abnormal_white_adipose | 0.66876128 |
| 123 | MP0003828_pulmonary_edema | 0.65996919 |
| 124 | MP0000367_abnormal_coat/_hair | 0.65818540 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.65481120 |
| 126 | MP0003115_abnormal_respiratory_system | 0.65411840 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.65378902 |
| 128 | MP0005165_increased_susceptibility_to | 0.64576842 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.64425521 |
| 130 | MP0001672_abnormal_embryogenesis/_devel | 0.64024424 |
| 131 | MP0005380_embryogenesis_phenotype | 0.64024424 |
| 132 | MP0001730_embryonic_growth_arrest | 0.63684894 |
| 133 | MP0005395_other_phenotype | 0.62449803 |
| 134 | MP0001340_abnormal_eyelid_morphology | 0.61812139 |
| 135 | MP0002970_abnormal_white_adipose | 0.59947047 |
| 136 | MP0003186_abnormal_redox_activity | 0.59743739 |
| 137 | MP0003656_abnormal_erythrocyte_physiolo | 0.57945591 |
| 138 | MP0003075_altered_response_to | 0.56195164 |
| 139 | MP0003119_abnormal_digestive_system | 0.56004524 |
| 140 | * MP0009765_abnormal_xenobiotic_induced | 0.54865745 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.54509594 |
| 142 | MP0009115_abnormal_fat_cell | 0.53579921 |
| 143 | MP0005388_respiratory_system_phenotype | 0.53422976 |
| 144 | MP0002133_abnormal_respiratory_system | 0.53422976 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.52681342 |
| 146 | * MP0008873_increased_physiological_sensi | 0.52414944 |
| 147 | * MP0009764_decreased_sensitivity_to | 0.52005115 |
| 148 | MP0000762_abnormal_tongue_morphology | 0.51868101 |
| 149 | MP0001764_abnormal_homeostasis | 0.51867551 |
| 150 | MP0009763_increased_sensitivity_to | 0.50745760 |
| 151 | MP0003950_abnormal_plasma_membrane | 0.50192305 |
| 152 | MP0001614_abnormal_blood_vessel | 0.49912761 |
| 153 | MP0002092_abnormal_eye_morphology | 0.47798466 |
| 154 | * MP0008469_abnormal_protein_level | 0.44681975 |
| 155 | MP0002128_abnormal_blood_circulation | 0.43775972 |
| 156 | MP0002932_abnormal_joint_morphology | 0.42871155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.49510448 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.12580794 |
| 3 | Bilateral microphthalmos (HP:0007633) | 5.06494452 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.06099306 |
| 5 | Polycythemia (HP:0001901) | 4.62810937 |
| 6 | Hepatoblastoma (HP:0002884) | 4.48073051 |
| 7 | J-shaped sella turcica (HP:0002680) | 4.45531580 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.44214888 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.19169668 |
| 10 | Xanthomatosis (HP:0000991) | 4.13353395 |
| 11 | Malnutrition (HP:0004395) | 4.03708541 |
| 12 | Asymmetry of the thorax (HP:0001555) | 4.01958964 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.95469133 |
| 14 | Vascular calcification (HP:0004934) | 3.88776298 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86718488 |
| 16 | Multiple enchondromatosis (HP:0005701) | 3.84590601 |
| 17 | Abnormal cartilage morphology (HP:0002763) | 3.73306717 |
| 18 | Septate vagina (HP:0001153) | 3.72728221 |
| 19 | Abnormality of the lower motor neuron (HP:0002366) | 3.69917123 |
| 20 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.69085539 |
| 21 | Skin nodule (HP:0200036) | 3.59010593 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.58009157 |
| 23 | Hyperglycinuria (HP:0003108) | 3.49233746 |
| 24 | Shawl scrotum (HP:0000049) | 3.36327540 |
| 25 | Cardiovascular calcification (HP:0011915) | 3.30693801 |
| 26 | Hyperacusis (HP:0010780) | 3.28669443 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 3.25294588 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.24971961 |
| 29 | Buphthalmos (HP:0000557) | 3.24663716 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.16165476 |
| 31 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.13947465 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.11139910 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 3.09839745 |
| 34 | Epidermoid cyst (HP:0200040) | 3.07635037 |
| 35 | Lip pit (HP:0100267) | 2.99566403 |
| 36 | Microglossia (HP:0000171) | 2.95333583 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 2.91141418 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.86253144 |
| 39 | Esophageal varix (HP:0002040) | 2.83541674 |
| 40 | Visceral angiomatosis (HP:0100761) | 2.82041010 |
| 41 | Rhinitis (HP:0012384) | 2.81554976 |
| 42 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.78625220 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.78506024 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.77616787 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77616787 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.77385971 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 2.76808900 |
| 48 | Hyperammonemia (HP:0001987) | 2.76330162 |
| 49 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.75794762 |
| 50 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.75794762 |
| 51 | Micronodular cirrhosis (HP:0001413) | 2.73839277 |
| 52 | Prolonged neonatal jaundice (HP:0006579) | 2.72742174 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.72278114 |
| 54 | Abdominal distention (HP:0003270) | 2.67312147 |
| 55 | Hyperphosphatemia (HP:0002905) | 2.64944110 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 2.61390163 |
| 57 | Rib fusion (HP:0000902) | 2.61313050 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.60855639 |
| 59 | Absent frontal sinuses (HP:0002688) | 2.59750223 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.59300458 |
| 61 | Abnormality of the pulmonary veins (HP:0011718) | 2.59198247 |
| 62 | Hemangiomatosis (HP:0007461) | 2.58928462 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.57226918 |
| 64 | Joint hemorrhage (HP:0005261) | 2.54798859 |
| 65 | Fat malabsorption (HP:0002630) | 2.54624411 |
| 66 | Gout (HP:0001997) | 2.54080804 |
| 67 | Curly hair (HP:0002212) | 2.51998049 |
| 68 | Vaginal fistula (HP:0004320) | 2.48824504 |
| 69 | Abnormality of the frontal sinuses (HP:0002687) | 2.46408446 |
| 70 | Amyloidosis (HP:0011034) | 2.45309163 |
| 71 | Congenital glaucoma (HP:0001087) | 2.44443751 |
| 72 | Hyperventilation (HP:0002883) | 2.44223858 |
| 73 | Abnormal ciliary motility (HP:0012262) | 2.43485214 |
| 74 | Back pain (HP:0003418) | 2.42132928 |
| 75 | Ketosis (HP:0001946) | 2.40456685 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 2.39693451 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.39693451 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.39586254 |
| 79 | Tetraplegia (HP:0002445) | 2.34513788 |
| 80 | Abnormality of the dental root (HP:0006486) | 2.34008500 |
| 81 | Taurodontia (HP:0000679) | 2.34008500 |
| 82 | Abnormality of permanent molar morphology (HP:0011071) | 2.34008500 |
| 83 | Metabolic acidosis (HP:0001942) | 2.33699195 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33593472 |
| 85 | Increased connective tissue (HP:0009025) | 2.33174359 |
| 86 | Amelogenesis imperfecta (HP:0000705) | 2.32710875 |
| 87 | Flat acetabular roof (HP:0003180) | 2.30696713 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29493753 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27985268 |
| 90 | Ulnar bowing (HP:0003031) | 2.27207770 |
| 91 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.25684480 |
| 92 | Pseudobulbar signs (HP:0002200) | 2.25204427 |
| 93 | Deformed sella turcica (HP:0002681) | 2.22606023 |
| 94 | Tetraparesis (HP:0002273) | 2.22024515 |
| 95 | Partial duplication of thumb phalanx (HP:0009944) | 2.22009497 |
| 96 | Ileus (HP:0002595) | 2.21464183 |
| 97 | Renal duplication (HP:0000075) | 2.20722066 |
| 98 | Steatorrhea (HP:0002570) | 2.19939874 |
| 99 | Hematochezia (HP:0002573) | 2.19382845 |
| 100 | Reticulocytosis (HP:0001923) | 2.18948723 |
| 101 | Complement deficiency (HP:0004431) | 2.17916262 |
| 102 | Overriding aorta (HP:0002623) | 2.16614726 |
| 103 | Testicular atrophy (HP:0000029) | 2.16511716 |
| 104 | Abnormality of molar (HP:0011077) | 2.15999773 |
| 105 | Abnormality of molar morphology (HP:0011070) | 2.15999773 |
| 106 | Ependymoma (HP:0002888) | 2.14620172 |
| 107 | Microcytic anemia (HP:0001935) | 2.14521645 |
| 108 | Peritonitis (HP:0002586) | 2.12642783 |
| 109 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.09308751 |
| 110 | Abnormality of the gastric mucosa (HP:0004295) | 2.09078732 |
| 111 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08820935 |
| 112 | Cardiomegaly (HP:0001640) | 2.08728483 |
| 113 | Abnormal hemoglobin (HP:0011902) | 2.08332651 |
| 114 | Thin bony cortex (HP:0002753) | 2.08206652 |
| 115 | Abnormal gallbladder physiology (HP:0012438) | 2.07428565 |
| 116 | Cholecystitis (HP:0001082) | 2.07428565 |
| 117 | Acanthocytosis (HP:0001927) | 2.07264257 |
| 118 | Pili torti (HP:0003777) | 2.07008537 |
| 119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.05291931 |
| 120 | Short humerus (HP:0005792) | 2.04816476 |
| 121 | Hypoparathyroidism (HP:0000829) | 2.03842631 |
| 122 | Widely patent fontanelles and sutures (HP:0004492) | 2.01897191 |
| 123 | Abnormality of the dental pulp (HP:0006479) | 2.00530587 |
| 124 | Bifid scrotum (HP:0000048) | 2.00322869 |
| 125 | Hyperparathyroidism (HP:0000843) | 1.99408076 |
| 126 | Short nail (HP:0001799) | 1.98540779 |
| 127 | Advanced eruption of teeth (HP:0006288) | 1.96703641 |
| 128 | Concave nail (HP:0001598) | 1.96584736 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.96210727 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 1.96210727 |
| 131 | Hypochromic anemia (HP:0001931) | 1.95599496 |
| 132 | Conjunctival telangiectasia (HP:0000524) | 1.94927928 |
| 133 | Long toe (HP:0010511) | 1.94020150 |
| 134 | Abnormality of the salivary glands (HP:0010286) | 1.93067848 |
| 135 | Reduced antithrombin III activity (HP:0001976) | 1.91494234 |
| 136 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.91352874 |
| 137 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91074910 |
| 138 | Lymphangioma (HP:0100764) | 1.90970677 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.90776035 |
| 140 | Neoplasm of striated muscle (HP:0009728) | 1.90548423 |
| 141 | Sparse lateral eyebrow (HP:0005338) | 1.90497284 |
| 142 | Achilles tendon contracture (HP:0001771) | 1.89697010 |
| 143 | Fused cervical vertebrae (HP:0002949) | 1.89349248 |
| 144 | Chronic bronchitis (HP:0004469) | 1.89070286 |
| 145 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88563712 |
| 146 | Anomalous pulmonary venous return (HP:0010772) | 1.88355577 |
| 147 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88194241 |
| 148 | Partial duplication of the phalanx of hand (HP:0009999) | 1.88153219 |
| 149 | Renal tubular acidosis (HP:0001947) | 1.86294831 |
| 150 | Abnormal hair laboratory examination (HP:0003328) | 1.85860021 |
| 151 | Bronchiectasis (HP:0002110) | 1.85752995 |
| 152 | Nasal polyposis (HP:0100582) | 1.85722185 |
| 153 | Hyperbilirubinemia (HP:0002904) | 1.85520458 |
| 154 | Spastic diplegia (HP:0001264) | 1.84826024 |
| 155 | Status epilepticus (HP:0002133) | 1.84764064 |
| 156 | Rectal fistula (HP:0100590) | 1.84233600 |
| 157 | Rectovaginal fistula (HP:0000143) | 1.84233600 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.83228570 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82613451 |
| 160 | Mucopolysacchariduria (HP:0008155) | 1.82613451 |
| 161 | Glomerulonephritis (HP:0000099) | 1.82531704 |
| 162 | Nephrolithiasis (HP:0000787) | 1.82045912 |
| 163 | Ketoacidosis (HP:0001993) | 1.80568474 |
| 164 | Mitral stenosis (HP:0001718) | 1.80486395 |
| 165 | Male infertility (HP:0003251) | 1.79758647 |
| 166 | Abnormality of the Achilles tendon (HP:0005109) | 1.79080642 |
| 167 | Delayed CNS myelination (HP:0002188) | 1.76949311 |
| 168 | Abnormality of methionine metabolism (HP:0010901) | 1.76893692 |
| 169 | Rickets (HP:0002748) | 1.76460924 |
| 170 | Camptodactyly of toe (HP:0001836) | 1.75994537 |
| 171 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.75666443 |
| 172 | Upper motor neuron abnormality (HP:0002127) | 1.75630465 |
| 173 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75483102 |
| 174 | Breast carcinoma (HP:0003002) | 1.74922043 |
| 175 | Rhabdomyosarcoma (HP:0002859) | 1.74197260 |
| 176 | Abnormality of complement system (HP:0005339) | 1.74170373 |
| 177 | Sensory axonal neuropathy (HP:0003390) | 1.73085673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.12916801 |
| 2 | ERN1 | 5.48491638 |
| 3 | GRK5 | 4.36653201 |
| 4 | GRK6 | 4.36449784 |
| 5 | TIE1 | 3.72707832 |
| 6 | TGFBR2 | 3.59691491 |
| 7 | GRK1 | 3.42382604 |
| 8 | RPS6KB2 | 3.03538131 |
| 9 | AKT3 | 2.86348221 |
| 10 | SMG1 | 2.81987306 |
| 11 | MAPKAPK3 | 2.74628661 |
| 12 | SCYL2 | 2.61684688 |
| 13 | PBK | 2.44284801 |
| 14 | TYRO3 | 2.31825352 |
| 15 | STK10 | 2.28558977 |
| 16 | MAP3K12 | 2.28491132 |
| 17 | TESK1 | 2.16829747 |
| 18 | CSF1R | 2.14889686 |
| 19 | PIK3CA | 2.14607891 |
| 20 | EIF2AK1 | 2.14170353 |
| 21 | NME2 | 2.10621879 |
| 22 | ADRBK2 | 2.09463854 |
| 23 | MATK | 2.00116683 |
| 24 | PRKG2 | 1.88090350 |
| 25 | MAPK7 | 1.82736381 |
| 26 | NEK6 | 1.81758651 |
| 27 | LMTK2 | 1.71019661 |
| 28 | RIPK1 | 1.69772564 |
| 29 | GRK7 | 1.67597802 |
| 30 | EPHA2 | 1.64514745 |
| 31 | IRAK3 | 1.52234964 |
| 32 | MAP2K4 | 1.46468610 |
| 33 | MOS | 1.38448987 |
| 34 | MAP3K10 | 1.34320779 |
| 35 | FGFR3 | 1.32499656 |
| 36 | TTK | 1.31271804 |
| 37 | PAK4 | 1.29200578 |
| 38 | MAPK15 | 1.28577132 |
| 39 | CSK | 1.27061629 |
| 40 | STK38 | 1.21305897 |
| 41 | TESK2 | 1.20169386 |
| 42 | MAP3K7 | 1.18995106 |
| 43 | WNK1 | 1.17519872 |
| 44 | NTRK1 | 1.17436289 |
| 45 | PDGFRA | 1.16764892 |
| 46 | CAMK4 | 1.16697369 |
| 47 | EEF2K | 1.12705055 |
| 48 | FGFR4 | 1.11799596 |
| 49 | MARK2 | 1.08044017 |
| 50 | SIK3 | 1.02622443 |
| 51 | MAP3K9 | 0.98050929 |
| 52 | MST4 | 0.97027853 |
| 53 | NME1 | 0.95082446 |
| 54 | EPHB1 | 0.90234435 |
| 55 | MAP2K6 | 0.87856896 |
| 56 | ADRBK1 | 0.86771012 |
| 57 | MAPK12 | 0.86692172 |
| 58 | TBK1 | 0.86506916 |
| 59 | CHUK | 0.83816661 |
| 60 | PTK2 | 0.80683981 |
| 61 | LATS1 | 0.80444728 |
| 62 | BCKDK | 0.79541069 |
| 63 | SIK1 | 0.78700941 |
| 64 | ILK | 0.77615046 |
| 65 | CAMK2G | 0.75983479 |
| 66 | LATS2 | 0.75858575 |
| 67 | PTK6 | 0.74828342 |
| 68 | MAP2K1 | 0.74585057 |
| 69 | CDK7 | 0.73546841 |
| 70 | MST1R | 0.72734942 |
| 71 | TRIB3 | 0.72686917 |
| 72 | EPHB2 | 0.71780373 |
| 73 | FRK | 0.71278119 |
| 74 | MUSK | 0.67182014 |
| 75 | HIPK2 | 0.63979074 |
| 76 | BMX | 0.62866506 |
| 77 | MAP3K1 | 0.58497833 |
| 78 | DDR2 | 0.58473115 |
| 79 | PIM2 | 0.57856234 |
| 80 | MAP2K3 | 0.57052403 |
| 81 | LIMK1 | 0.56837134 |
| 82 | MAP3K3 | 0.56548810 |
| 83 | CDK9 | 0.55150929 |
| 84 | TAOK1 | 0.54320711 |
| 85 | KDR | 0.53738373 |
| 86 | IGF1R | 0.53269915 |
| 87 | CDK8 | 0.49822239 |
| 88 | AKT2 | 0.48852730 |
| 89 | MET | 0.48572903 |
| 90 | VRK2 | 0.48471372 |
| 91 | ARAF | 0.48221689 |
| 92 | PRKD1 | 0.47477946 |
| 93 | RPS6KA2 | 0.46190464 |
| 94 | PKN2 | 0.45294712 |
| 95 | FGFR2 | 0.45055325 |
| 96 | ERBB2 | 0.44928542 |
| 97 | BRSK1 | 0.44896623 |
| 98 | MAPK4 | 0.44432711 |
| 99 | GSK3A | 0.44212225 |
| 100 | ALK | 0.43525740 |
| 101 | ITK | 0.43319792 |
| 102 | CAMK2B | 0.43300575 |
| 103 | CDK6 | 0.42373211 |
| 104 | MTOR | 0.42074780 |
| 105 | STK16 | 0.41854319 |
| 106 | DYRK1B | 0.40017716 |
| 107 | RET | 0.38794395 |
| 108 | PDPK1 | 0.36802290 |
| 109 | MAP3K8 | 0.35597239 |
| 110 | EIF2AK3 | 0.34956355 |
| 111 | PRKAA2 | 0.34793257 |
| 112 | MAP3K6 | 0.34617015 |
| 113 | PRKACG | 0.34565143 |
| 114 | NEK1 | 0.33755419 |
| 115 | PRKCH | 0.33745672 |
| 116 | ICK | 0.33335824 |
| 117 | PRKD2 | 0.33162452 |
| 118 | EGFR | 0.33086365 |
| 119 | MELK | 0.33086227 |
| 120 | FER | 0.32283395 |
| 121 | DAPK1 | 0.31328168 |
| 122 | PDK1 | 0.31271481 |
| 123 | LRRK2 | 0.30799522 |
| 124 | TRPM7 | 0.30777037 |
| 125 | RPS6KB1 | 0.30331318 |
| 126 | JAK2 | 0.29942670 |
| 127 | MAP3K2 | 0.29700129 |
| 128 | TAOK2 | 0.29698621 |
| 129 | MAPKAPK2 | 0.29676131 |
| 130 | AURKA | 0.29521537 |
| 131 | KSR2 | 0.28914717 |
| 132 | CAMK2D | 0.28739375 |
| 133 | PAK3 | 0.28210564 |
| 134 | YES1 | 0.28018261 |
| 135 | SRC | 0.27601953 |
| 136 | MAP3K11 | 0.27571528 |
| 137 | ERBB4 | 0.26272349 |
| 138 | PRKCI | 0.25424317 |
| 139 | PRKCD | 0.24343968 |
| 140 | STK38L | 0.24314154 |
| 141 | CDC42BPA | 0.23543755 |
| 142 | MAPK11 | 0.23393713 |
| 143 | TGFBR1 | 0.23314961 |
| 144 | PRPF4B | 0.22924088 |
| 145 | ABL2 | 0.22524879 |
| 146 | PDK2 | 0.22492861 |
| 147 | INSR | 0.22462703 |
| 148 | MAP2K2 | 0.22114690 |
| 149 | PAK2 | 0.22084193 |
| 150 | PDGFRB | 0.20753935 |
| 151 | MYLK | 0.19492950 |
| 152 | INSRR | 0.18067277 |
| 153 | PRKAA1 | 0.17393494 |
| 154 | CHEK2 | 0.16893023 |
| 155 | KIT | 0.16826006 |
| 156 | EIF2AK2 | 0.16239462 |
| 157 | PTK2B | 0.15145369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 9.44224173 |
| 2 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.07385110 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04235936 |
| 4 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.90635780 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.83915780 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.58365583 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57880628 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.50892844 |
| 9 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.33913335 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11889270 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.04818467 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03168076 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.99254803 |
| 14 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.97685009 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.69173143 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67569247 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65785809 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58575994 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.57763522 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56218097 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52743096 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47486251 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.42981987 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42933406 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36695381 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35298623 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34603296 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28889610 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.17527645 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16072395 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11961737 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10356683 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08240564 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05481147 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05457187 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05229305 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04425113 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01851735 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00527575 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.00309124 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98410678 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94569267 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92609324 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92585862 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87984327 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86894448 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84534443 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.83845059 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.78851152 |
| 50 | Proteasome_Homo sapiens_hsa03050 | 0.78349186 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77305586 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76906030 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74194412 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72400883 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71211460 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70895081 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68007006 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67997431 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67730206 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67681954 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66416435 |
| 62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65932385 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65840876 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62772394 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62613721 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60157895 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59639582 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58394690 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.56779434 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56455038 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55957903 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53309375 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52570911 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52351421 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.51500208 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.50817292 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50766907 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49088977 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48200463 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.48156167 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48079898 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47989982 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46199633 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45388584 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43675329 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42788860 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42391505 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41489933 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39590438 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.38131212 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35770235 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34948261 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34652388 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33982555 |
| 95 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32543654 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31980092 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30791146 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.27870336 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27075306 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26615155 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24925255 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24549455 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23043887 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22383733 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22112898 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.22093124 |
| 107 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.21425777 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20996440 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.20634752 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17194715 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16004289 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15785589 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11934257 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11708747 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.10245506 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.10189308 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.09526228 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08008523 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.07454996 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06818203 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05674630 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.04593857 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.04387527 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03472847 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.02315051 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00792344 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.00416021 |
| 128 | Tight junction_Homo sapiens_hsa04530 | -0.0110489 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | -0.0107077 |

